GlassScriptPhysician profile
Chaundre K Cross
NPI 1972506707
$131,131.49
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $37K · 2021: $60K · 2022: $13K.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $88,121.25 | 2019-2022 | |
| Astellas Pharma US INC | $19,083.57 | 2019-2022 | |
| Pfizer INC. | $13,903.64 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $3,520.84 | 2019-2022 | |
| Novocure INC. | $2,789.69 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $2,224.89 | 2020 | |
| Dendreon Pharmaceuticals LLC | $190.31 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $183.30 | 2019-2020 | |
| Boston Scientific Corporation | $178.83 | 2019-2022 | |
| Foundation Medicine, INC. | $178.40 | 2020-2022 | |
| Sirtex Medical INC | $158.86 | 2019 | |
| Blue Earth Diagnostics | $136.18 | 2019-2021 | |
| Genzyme Corporation | $125.00 | 2019 | |
| Eisai INC. | $109.79 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $54.23 | 2019-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $41.76 | 2022 | |
| Palette Life Sciences, INC. | $39.04 | 2022 | |
| Myovant Sciences INC. | $30.30 | 2021-2022 | |
| Monteris Medical Corporation | $23.59 | 2022 | |
| Myriad Genetic Laboratories, INC. | $13.32 | 2021 | |
| Amgen INC. | $13.10 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chaundre Cross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.